Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Jun 0808:00 PM EDT
-10:00 PM EDT
Master the GMAT with expert live instruction, a personalized study plan, and real-time support. Includes 40 hours of online classes plus 6 months of access to the TTP GMAT OnDemand video course. Mon/Wed June 8, 2026 →August 12, 2026 8:00pm-10:00pm EST
Jun 1006:00 AM PDT
-06:15 PM PDT
Register for the GMAT Club Virtual MBA Spotlight Fair – the world’s premier event for serious MBA candidates. This is your chance to hear directly from Admissions Directors at nearly every Top 30 MBA program..- Jun 10
10:00 AM PDT
-11:00 AM PDT
Scoring 715 on the GMAT Focus Edition requires more than just learning formulas, memorizing concepts, or solving hundreds of questions. In this episode, Nishant shares how he improved his GMAT preparation by focusing on application of concepts, and more. 
Jun 1111:00 AM EDT
-01:00 PM EDT
TTP GMAT OnDemand gives serious students 400+ hours of expert video instruction, the full TTP course, AI support, weekly office hours, and a 715+ score guarantee—all built for elite GMAT score improvement.
1: not use carbapenem
2: no change in mortality risk
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
35%
(medium)
Question Stats:
34% (02:01) correct
66%
(02:11)
wrong
based on 658
sessions
History
Date
Time
Result
Not Attempted Yet
A study was conducted to determine the effects of using a specific type of antibiotic, carbapenems, on critically ill patients with bacterial infections. The researchers divided the patients into two groups: those who received carbapenems and those who did not. The study had two main goals: to determine whether carbapenems reduced mortality and to assess whether prolonged carbapenem use increased the likelihood of developing multidrug-resistant (MDR) pathogens.
Results indicated that there was no significant difference in mortality between the two groups, but patients who received carbapenems for a longer duration were more likely to have new MDR pathogens detected.
Statement: If a doctor wanted to minimize the likelihood of developing MDR pathogens, she would be more likely to X on critically ill patients with bacterial infections, which would result in Y as compared to carbapenem treatment.
Select for __1__ and for __2__ the options that complete the statement so that it most accurately reflects the information provided. Make only two selections, one in each column.
Results indicated that there was no significant difference in mortality between the two groups, but patients who received carbapenems for a longer duration were more likely to have new MDR pathogens detected.
Statement: If a doctor wanted to minimize the likelihood of developing MDR pathogens, she would be more likely to X on critically ill patients with bacterial infections, which would result in Y as compared to carbapenem treatment.
Select for __1__ and for __2__ the options that complete the statement so that it most accurately reflects the information provided. Make only two selections, one in each column.
| 1 | 2 | |
| use carbapenems | ||
| not use carbapenem | ||
| an increase in mortality risk | ||
| a decrease in mortality risk | ||
| no change in mortality risk |
ShowHide Answer
Official Answer
1: not use carbapenem
2: no change in mortality risk
15 Apr 2025, 07:05
Kudos
Bookmarks
Official Solution:
1. What would the doctor do to minimize the likelihood of developing MDR pathogens?
• The study says prolonged carbapenem use increases MDR pathogens.
• To minimize this risk, the doctor would be more likely to not use carbapenem.
Correct selection for 1 → not use carbapenem
2. What would be the impact on mortality compared to carbapenem treatment?
• The study says there was no significant difference in mortality between the group that received carbapenems and the group that did not.
Correct selection for 2 → no change in mortality risk
Correct answer:
1 "not use carbapenem"
2 "no change in mortality risk"
Bunuel
1. What would the doctor do to minimize the likelihood of developing MDR pathogens?
• The study says prolonged carbapenem use increases MDR pathogens.
• To minimize this risk, the doctor would be more likely to not use carbapenem.
Correct selection for 1 → not use carbapenem
2. What would be the impact on mortality compared to carbapenem treatment?
• The study says there was no significant difference in mortality between the group that received carbapenems and the group that did not.
Correct selection for 2 → no change in mortality risk
Correct answer:
1 "not use carbapenem"
2 "no change in mortality risk"
General Discussion
16 Sep 2024, 17:28
Kudos
Bookmarks
Here's the official solution:
There are two pieces of relevant information in the prompt:
To minimize the risk of detecting MDR pathogens (which was linked to prolonged carbapenem use), the doctor would likely choose not to use carbapenem. Regarding mortality, the study states there was no change in mortality risk between those who did and did not use carbapenems.
Thus, the best selections are:
There are two pieces of relevant information in the prompt:
- Carbapenem use and mortality: The study shows no significant difference in mortality between the group that received carbapenems and the group that did not.
- Carbapenem use and MDR pathogens: The study found that a longer duration of carbapenem use increased the risk of detecting multidrug-resistant (MDR) pathogens.
To minimize the risk of detecting MDR pathogens (which was linked to prolonged carbapenem use), the doctor would likely choose not to use carbapenem. Regarding mortality, the study states there was no change in mortality risk between those who did and did not use carbapenems.
Thus, the best selections are:
- X: Not use carbapenem
- Y: No change in mortality risk
